SCHEMBL106915

SCHEMBL106915

CC(=O)CCCc1ccc(O)cc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 3/20 0.53
ACHE P22303 3/20 0.53
ADRA2A P08913 2/20 0.53
ADORA3 P0DMS8 2/20 0.53
TACR2 P21452 2/20 0.53
SLC6A2 P23975 2/20 0.53
SLC6A4 P31645 2/20 0.53
SLC6A3 Q01959 2/20 0.53
KDM4E B2RXH2 2/20 0.53
HSD17B10 Q99714 2/20 0.53
ALDH1A1 P00352 2/20 0.53
LMNA P02545 1/20 0.53
SHBG P04278 1/20 0.53
TP53 P04637 1/20 0.53
CYP3A4 P08684 1/20 0.53
HSPD1 P10809 1/20 0.53
ADRB3 P13945 1/20 0.53
HTR2C P28335 1/20 0.53
HSPE1 P61604 1/20 0.53
HIF1A Q16665 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2565118 0.94 ACHE (0.57) ESR1ACHEADRA2AADORA3TACR2
SCHEMBL9834899 0.92 ACHE (0.60) ESR1ACHEADRA2AADORA3TACR2
SCHEMBL5537458 0.92 ACHE (0.60) ESR1ACHEADRA2AADORA3TACR2
SCHEMBL4383632 0.92 ACHE (0.60) ESR1ACHEADRA2AADORA3TACR2
Raspberryketone SCHEMBL43308 0.87 ALDH1A1 (0.65) ESR1ACHEADRA2AADORA3TACR2
SCHEMBL1697201 0.85 TRPV1 (0.54) ESR1ACHEADRA2AADORA3TACR2
Raspberryketone SCHEMBL8759829 0.83 ALDH1A1 (0.61) ESR1ACHEADRA2AADORA3TACR2
Raspberryketone SCHEMBL593164 0.83 ALDH1A1 (0.67) ESR1ADRA2ASLC6A2SLC6A3KDM4E
SCHEMBL105767 0.83 HSD17B10 (0.52) SLC6A3HSD17B10ALDH1A1PLAAT3PLAAT5
SCHEMBL27352245 0.83 HSD17B10 (0.52) SLC6A3HSD17B10ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 62 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116253626-B Alcohol ether compound and application thereof in water-based nano pesticide preparation 中国农业科学院农业环境与可持续发展研究所 2023-09-01 CN claimed
CN-116253626-A Alcohol ether compound and application thereof in water-based nano pesticide preparation 中国农业科学院农业环境与可持续发展研究所 2023-06-13 CN claimed
CN-115521249-A 2- [4- (1-oxoalkyl) phenoxy ] -3-picolinic acid, preparation method and application thereof 沈阳兴齐眼药股份有限公司 2022-12-27 CN claimed
EP-2195440-A2 BIOFUEL PRODUCTION Bio Architecture Lab, Inc. (US) 2010-06-16 EP claimed
WO-2009046370-A2 BIOFUEL PRODUCTION BIO ARCHITECTURE LAB, INC. (US) 2009-04-09 WO claimed
WO-2009046375-A2 BIOFUEL PRODUCTION BIO ARCHITECTURE LAB, INC. (US) 2009-04-09 WO claimed
CN-119978345-A Polyether modified amphiphilic carboxylic acid derivative and application thereof in nano pesticide 中国农业科学院农业环境与可持续发展研究所 2025-05-13 CN disclosed
CN-115521249-B 2- [4- (1-Oxo alkyl) phenoxy ] -3-picolinic acid, preparation method and application thereof 沈阳兴齐眼药股份有限公司 2025-03-11 CN disclosed
CN-115521251-B Pranoprofen intermediate compound, preparation method and application thereof 沈阳兴齐眼药股份有限公司 2024-12-27 CN disclosed
US-11767289-B2 Methods and compositions for pest control UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY OF AGRICULTURE (US) 2023-09-26 US disclosed
CN-115521320-B Method for preparing pranoprofen 沈阳兴齐眼药股份有限公司 2023-09-05 CN disclosed
CN-116253626-B Alcohol ether compound and application thereof in water-based nano pesticide preparation 中国农业科学院农业环境与可持续发展研究所 2023-09-01 CN disclosed
CN-116253626-A Alcohol ether compound and application thereof in water-based nano pesticide preparation 中国农业科学院农业环境与可持续发展研究所 2023-06-13 CN disclosed
WO-2009046375-A2 BIOFUEL PRODUCTION BIO ARCHITECTURE LAB, INC. (US) 2009-04-09 WO disclosed
WO-2009046370-A2 BIOFUEL PRODUCTION BIO ARCHITECTURE LAB, INC. (US) 2009-04-09 WO disclosed
US-7262212-B2 2,3-dihydro-6-nitroimidazo[2,1-b]oxazoles OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2007-08-28 US disclosed
US-20060094767-A1 2,3-Dihydro-6-nitroimidazo[2,1-b]oxazoles OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2006-05-04 US disclosed
CN-1705670-A 2, 3-dihydro-6-nitroimidazo [2, 1-b ] oxazole compounds OTSUKA PHARMA CO LTD (JP) 2005-12-07 CN disclosed
EP-1555267-A1 2,3-DIHYDRO-6-NITROIMIDAZO 2,1-b OXAZOLES OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2005-07-20 EP disclosed
EP-0426804-A1 2-(2-HYDROXY-3-PHENOXYPROPYLAMINO)-ETHOXYBENZENE DERIVATIVES. ICI PLC (GB) 1991-05-15 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060094767-A1 2,3-Dihydro-6-nitroimidazo[2,1-b]oxazoles NR2C2, NR4A3, NR4A2 ESR1 1578/4885ACHE 4670/4885ADRA2A 746/4885
US-11767289-B2 Methods and compositions for pest control TYR, GLMN, SGMS2 ESR1 4620/4885ACHE 24/4885ADRA2A 2823/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.